{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:11:25Z","timestamp":1790626285236,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.tips.2013.04.001","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T21:51:18Z","timestamp":1367445078000},"page":"332-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?"],"prefix":"10.1016","volume":"34","author":[{"given":"Stephen M.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2013.04.001_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2011.05.054","article-title":"Pregabalin is a potent and selective ligand for \u03b1(2)\u03b4-1 and \u03b1(2)\u03b4-2 calcium channel subunits","volume":"667","author":"Li","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2013.04.001_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1124\/jpet.111.180976","article-title":"Anxiolytic-like activity of pregabalin in the Vogel conflict test in \u03b12\u03b4-1 (R217A) and \u03b12\u03b4-2 (R279A) mouse mutants","volume":"338","author":"Lotarski","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2013.04.001_bib0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neuroscience.2008.05.053","article-title":"Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (alpha2-delta) type 1 protein","volume":"155","author":"Taylor","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2013.04.001_bib0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.yebeh.2012.02.005","article-title":"Pregabalin increases slow-wave sleep and may improve attention in patients with partial epilepsy and insomnia","volume":"23","author":"Bazil","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.tips.2013.04.001_bib0025","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1185\/03007995.2010.516142","article-title":"The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials","volume":"26","author":"Roth","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.tips.2013.04.001_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4321\/S0213-61632010000100003","article-title":"Pregabalin reduces sleep disturbance in patients with generalized anxiety disorder via both direct and indirect mechanisms","volume":"24","author":"Bollu","year":"2010","journal-title":"Eur. J. Psychiatry"},{"key":"10.1016\/j.tips.2013.04.001_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/sleep\/28.2.187","article-title":"A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo","volume":"28","author":"Hindmarch","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.tips.2013.04.001_bib0040","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1212\/WNL.0b013e3181e1ce73","article-title":"Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study","volume":"74","author":"Garcia-Borreguero","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2013.04.001_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/nau.20928","article-title":"Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder","volume":"30","author":"Marencak","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.tips.2013.04.001_bib0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.pain.2010.12.023","article-title":"Safety and efficacy of pregabalin in patients with central post-stroke pain","volume":"152","author":"Kim","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/mol.112.077636","article-title":"alpha2delta ligands act as positive modulators of adult hippocampal neurogenesis and prevent depression-like behavior induced by chronic restraint stress","volume":"82","author":"Valente","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.04.001_bib0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrn3311","article-title":"Calcium channel auxiliary alpha2delta and beta subunits: trafficking and one step beyond","volume":"13","author":"Dolphin","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2013.04.001_bib0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jpain.2010.02.024","article-title":"Central sensitization and Ca(V)\u03b12\u03b4 ligands in chronic pain syndromes: pathologic processes and pharmacologic effect","volume":"11","author":"Tuchman","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuron.2012.02.027","article-title":"Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC alpha(2)delta-1 subunit","volume":"74","author":"Senatore","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.04.001_bib0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.tips.2013.04.001_bib0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nbd.2012.06.019","article-title":"Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma","volume":"48","author":"Li","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2013.04.001_bib0085","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1523\/JNEUROSCI.6494-11.2012","article-title":"Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states","volume":"32","author":"Kim","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.04.001_bib0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tips.2013.04.001_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0074-7742(06)81006-8","article-title":"Mechanisms of action of antiepileptic drugs","volume":"81","author":"White","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.tips.2013.04.001_bib0100","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2147\/NDT.S4716","article-title":"Pregabalin for the management of partial epilepsy","volume":"4","author":"Ryvlin","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.tips.2013.04.001_bib0105","first-page":"1062","article-title":"Gabapentin: an update of its pharmacological properties and therapeutic use in epilepsy","volume":"16","author":"Honarmand","year":"2011","journal-title":"J. Med. Sci. Res."},{"key":"10.1016\/j.tips.2013.04.001_bib0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0920-1211(91)90018-B","article-title":"The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice","volume":"9","author":"Chapman","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.tips.2013.04.001_bib0115","first-page":"709","article-title":"Common pathophysiologic mechanisms in migraine and epilepsy","volume":"65","author":"Rogawski","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tips.2013.04.001_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11910-010-0099-1","article-title":"Cortical spreading depression and migraine","volume":"10","author":"Eikermann-Haerter","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.tips.2013.04.001_bib0125","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/jcbfm.2010.92","article-title":"Gabapentin suppresses cortical spreading depression susceptibility","volume":"30","author":"Hoffmann","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.tips.2013.04.001_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.05.025","article-title":"Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology","volume":"1401","author":"Quintero","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2013.04.001_bib0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/chan.5.2.14149","article-title":"Role of different voltage-gated Ca2+ channels in cortical spreading depression: specific requirement of P\/Q-type Ca2+ channels","volume":"5","author":"Tottene","year":"2011","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.tips.2013.04.001_bib0140","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.pain.2010.12.004","article-title":"Role of voltage-dependent calcium channel subtypes in spinal long-term potentiation of C-fiber-evoked field potentials","volume":"152","author":"Ohnami","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00000542-199801000-00028","article-title":"Characterization of the effects of gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia","volume":"88","author":"Partridge","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tips.2013.04.001_bib0155","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1213\/ANE.0b013e31820f2a16","article-title":"The effects of intrathecal and systemic gabapentin on spinal substance P release","volume":"112","author":"Takasusuki","year":"2011","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.tips.2013.04.001_bib0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1471-4159.2010.06625.x","article-title":"Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate","volume":"113","author":"Kumar","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.04.001_bib0165","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.0409066103","article-title":"Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin","volume":"103","author":"Field","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.04.001_bib0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/BST0380525","article-title":"The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo","volume":"38","author":"Bauer","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tips.2013.04.001_bib0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JPR.S7884","article-title":"Pregabalin for the management of fibromyalgia syndrome","volume":"3","author":"Boomershine","year":"2010","journal-title":"J. Pain Res."},{"key":"10.1016\/j.tips.2013.04.001_bib0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jnr.22512","article-title":"Central amplification and fibromyalgia: disorder of pain processing","volume":"89","author":"Petersel","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tips.2013.04.001_bib0185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/ACO.0b013e32833c348b","article-title":"Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states","volume":"23","author":"Yarnitsky","year":"2010","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.tips.2013.04.001_bib0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","article-title":"Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition","volume":"114","author":"Julien","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0195","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1172\/JCI43766","article-title":"Central modulation of pain","volume":"120","author":"Ossipov","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2013.04.001_bib0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpain.2010.05.005","article-title":"A tropomyosine receptor kinase inhibitor blocks spinal neuroplasticity essential for the anti-hypersensitivity effects of gabapentin and clonidine in rats with peripheral nerve injury","volume":"12","author":"Hayashida","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2005.10.032","article-title":"Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury","volume":"198","author":"Suzuki","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2013.04.001_bib0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejphar.2008.09.004","article-title":"Multiplicative interactions to enhance gabapentin to treat neuropathic pain","volume":"598","author":"Hayashida","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2013.04.001_bib0215","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/ALN.0b013e318254e6fd","article-title":"Gabapentin inhibits \u03b3-amino butyric acid release in the locus coeruleus but not in the spinal dorsal horn after peripheral nerve injury in rats","volume":"116","author":"Yoshizumi","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tips.2013.04.001_bib0220","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuropharm.2007.08.013","article-title":"Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model","volume":"53","author":"Takeuchi","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2013.04.001_bib0225","series-title":"Synaptic Self: How Our Brains Become Who We Are","author":"LeDoux","year":"2002"},{"key":"10.1016\/j.tips.2013.04.001_bib0230","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/11634510-000000000-00000","article-title":"Elucidating the mechanism of action of pregabalin: \u03b1(2)\u03b4 as a therapeutic target in anxiety","volume":"26","author":"Mic\u00f3","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tips.2013.04.001_bib0235","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/npp.2011.32","article-title":"Pregabalin influences insula and amygdala activation during anticipation of emotional images","volume":"36","author":"Aupperle","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.04.001_bib0240","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-007-1004-8","article-title":"Escitalopram effects on insula and amygdala BOLD activation during emotional processing","volume":"196","author":"Arce","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2013.04.001_bib0245","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuroimage.2009.10.013","article-title":"Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study","volume":"49","author":"Windischberger","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.tips.2013.04.001_bib0250","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YIC.0b013e328350b133","article-title":"Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment","volume":"27","author":"Rickels","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2013.04.001_bib0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000117423.05703.e7","article-title":"Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study","volume":"24","author":"Pande","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2013.04.001_bib0260","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam","volume":"62","author":"Rickels","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2013.04.001_bib0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145709990460","article-title":"Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder","volume":"13","author":"Lydiard","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2013.04.001_bib0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000328431","article-title":"Possible sites of therapeutic action in restless legs syndrome: focus on dopamine and \u03b12\u03b4 ligands","volume":"66","author":"Thorpe","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.tips.2013.04.001_bib0275","series-title":"Sleep and Pain","first-page":"3","article-title":"What is sleep, and why do we sleep?","author":"Peever","year":"2007"},{"key":"10.1016\/j.tips.2013.04.001_bib0280","first-page":"721","article-title":"Neural mechanism of rapid eye movement sleep generation with reference to REM-OFF neurons in locus coeruleus","volume":"125","author":"Pal","year":"2007","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.tips.2013.04.001_bib0285","doi-asserted-by":"crossref","first-page":"P48","DOI":"10.1016\/j.jpain.2011.02.195","article-title":"Prediction of pain response by severity of sleep interference in neuropathic pain","volume":"12","author":"Vinik","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0290","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1528-1157.2002.21002.x","article-title":"Gabapentin increases slow-wave sleep in normal adults","volume":"43","author":"Foldvary-Schaefer","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2013.04.001_bib0295","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1528-1167.2010.02966.x","article-title":"The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"Zaccara","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2013.04.001_bib0300","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/WNL.0b013e3181d25b34","article-title":"Cognitive effects of pregabalin in healthy volunteers: a double-blind, placebo-controlled trial","volume":"74","author":"Salinsky","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2013.04.001_bib0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel \u03b12\u03b4 ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2013.04.001_bib0310","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1185\/03007995.2012.684044","article-title":"Characterizing and understanding body weight patterns in patients treated with pregabalin","volume":"28","author":"Cabrera","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.tips.2013.04.001_bib0315","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/ALN.0b013e31818dac9c","article-title":"Gabapentin acts within the locus coeruleus to alleviate neuropathic pain","volume":"109","author":"Hayashida","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tips.2013.04.001_bib0320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pain.2008.08.008","article-title":"Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin","volume":"140","author":"Bee","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0325","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jpain.2012.01.130","article-title":"Pregabalin alters default mode network activity in fibromyalgia","volume":"13","author":"Hampson","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2013.04.001_bib0330","first-page":"S381","article-title":"Pregabalin reduces posterior insula glutamate and glutamine (Glx) in fibromyalgia (FM)","volume":"63","author":"Harris","year":"2011","journal-title":"Arthritis Rheum."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471300062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471300062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:06:02Z","timestamp":1759050362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016561471300062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S016561471300062X"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2013.04.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2013.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}